Back to overview

Neumirna Wins Nordic Star Award at NLS Days 2023

Neumirna has been awarded the Nordic Star Award at NLS Days 2023, recognizing the company as the start-up with the highest investment potential.

The award was presented following the conference’s pitch competition, highlighting Neumirna’s innovative RNA-based approach to treating neurological diseases and its strong promise in the biotech space.

Funding
Awards
12.6.2025
Neumirna Receives 2024 CURE Epilepsy Catalyst Award
$250,000 in funding to support biomarker research and development of RNA therapy for drug-resistant epilepsy
Read full article
Awards
Funding
11.6.2025
Neumirna Receives 2025 Epilepsy Foundation Shark Tank Investment
$200,000 award supports Neumirna’s RNA-based approach to innovation in epilepsy treatment
Read full article
Awards
27.3.2025
Neumirna Wins Nordic Star Award at NLS Days 2023
Neumirna has been awarded the Nordic Star Award at NLS Days 2023, recognizing the company as the start-up with the highest investment potential.
Read full article